CMMB Chemomab Therapeutics Ltd. - American Depositary Shares
$1,60
Preço · Mai 20, 2026
Fundamentais a partir de Mai 11, 2023
Intervalo 52 Semanas
$1–$6
6% of range
Classificação do Analista
BUY
8 analysts
Preço-Alvo
$15
+838% upside
P/E (TTM)
—
ROE
—
Margem de Lucro Líquido
—
CMMB Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$1.60
Capitalização de Mercado
—
P/E (TTM)
—
EPS (TTM)
—
Receita (TTM)
—
Rendimento div.
—
ROE
—
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $6
CMMB Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
—
EPS
—
2021-12-31
→
2022-12-31
Fluxo de caixa livre
—
2019-12-31
→
2022-12-31
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
CMMB
Mediana de Pares
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
CMMB
Mediana de Pares
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
CMMB
Mediana de Pares
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
CMMB
Mediana de Pares
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
CMMB
Mediana de Pares
CMMB Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
8 analistas
- Compra forte 3 37,5%
- Compra 4 50,0%
- Manter 1 12,5%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
2 analistas · 2026-05-14
Mediana
$15.00
← Abaixo de todos os alvos
$1.60
Mín
$5.00
Máx
$25.00
Alvo mediano
$15.00
+837,5%
Alvo médio
$15.00
+837,5%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-0.43%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-0.24 | $-0.16 | -0.08% |
| 31 de Dezembro de 2025 | $-0.24 | $-0.32 | 0.08% |
| 31 de Março de 2025 | $-0.56 | $-0.04 | -0.52% |
| 31 de Dezembro de 2024 | $-0.64 | $-0.32 | -0.32% |
| 30 de Setembro de 2024 | $-0.80 | $-0.02 | -0.78% |
| 30 de Junho de 2024 | $-1.04 | $-0.06 | -0.98% |
Comparação com pares Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| CMMB | — | — | — | — | — | — |
| NRSN | — | — | — | — | — | — |
| PLUR | $39M | -1.4 | 309.8% | -1690.3% | 669.5% | 48.9% |
| PLRZ | — | — | — | — | — | — |
| QNRX | $757M | — | — | — | -201.7% | — |
| EVGN | — | — | — | — | — | — |
| CLGN | — | — | — | — | — | — |
| GLMD | — | — | — | — | — | — |
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 11
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| R&D Expense | $17M | $6M | $5M | $13M | $8M | |
| SG&A Expense | $12M | $6M | $1M | $6M | $6M | |
| Operating Expenses | $29M | $12M | $6M | $23M | $13M | |
| Other Non-op | $353.0K | $-111.0K | · | · | · | |
| Pretax Income | $-28M | $-12M | $6M | $27M | $13M | |
| Income Tax | $-534.0K | $0 | · | $0 | $306.0K | |
| Net Income | $-28M | $-12M | $-6M | $-27M | $-14M | |
| EPS (Basic) | $0.12 | $0.06 | · | · | · | |
| EPS (Diluted) | $0.12 | $0.06 | · | · | · | |
| Shares (Basic) | 227,589,288 | 207,468,650 | · | · | · | |
| Shares (Diluted) | 227,589,288 | 207,468,650 | · | · | · |
Balanço Patrimonial 20
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $15M | $12M | $18M | $8M | |
| Receivables | · | · | · | $408.0K | $3M | |
| Prepaid Expense | $2M | $2M | $141.0K | $636.0K | · | |
| Current Assets | $42M | $63M | $12M | $18M | $11M | |
| PP&E (Net) | $367.0K | $357.0K | $152.0K | $158.0K | $385.0K | |
| PP&E (Gross) | $532.0K | $464.0K | $225.0K | · | · | |
| Accum. Depreciation | $165.0K | $107.0K | $73.0K | · | · | |
| Other Non-current Assets | · | · | $51.0K | $57.0K | · | |
| Total Assets | $43M | $64M | $12M | $20M | $13M | |
| Accrued Liabilities | $3M | $555.0K | $715.0K | $372.0K | $2M | |
| Current Liabilities | $7M | $3M | $1M | $4M | $3M | |
| Capital Leases | $91.0K | $237.0K | $358.0K | $725.0K | · | |
| Total Liabilities | $7M | $3M | $2M | $5M | $3M | |
| Common Stock | $0 | $0 | · | · | · | |
| Paid-in Capital | $101M | $98M | $34M | $119M | $87M | |
| Retained Earnings | $-64M | $-36M | $-24M | $-105M | $-78M | |
| Treasury Stock | $1M | $0 | · | · | · | |
| Stockholders' Equity | $36M | $61M | $11M | $12M | $10M | |
| Liabilities + Equity | $43M | $64M | $12M | $20M | $13M | |
| Shares Outstanding | 232,636,700 | 228,090,300 | 9,274,838 | 37,099,352 | 15,575,682 |
Fluxo de Caixa 11
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $130.0K | $1M | $2M | |
| Restructuring | · | · | $749.0K | $3M | · | |
| Operating Cash Flow | $-20M | $-12M | $-5M | $-16M | $-14M | |
| CapEx | $68.0K | $239.0K | $38.0K | $95.0K | $213.0K | |
| Investing Cash Flow | $20M | $-45M | $-62.0K | $-95.0K | $-213.0K | |
| Stock Issued | · | · | $0 | $30M | $23M | |
| Net Stock Activity | · | · | $0 | $30M | · | |
| Financing Cash Flow | $-808.0K | $61M | $5M | $27M | $21M | |
| Net Change in Cash | $-2M | $4M | $-554.0K | $10M | $6M | |
| Taxes Paid | $5.0K | $0 | $84.0K | $161.0K | $244.0K | |
| Free Cash Flow | $-20M | $-13M | $-13M | $-17M | · |
Lucratividade 2
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| ROA | -51.5% | -32.5% | -89.5% | -166.8% | · | |
| ROE | -62.8% | -19.7% | -147.6% | -153.6% | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 23.7 | 2.4 | 4.4 | · | |
| Quick Ratio | 2.0 | 5.7 | 2.1 | 4.4 | · |
Taxas de Crescimento 1
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| EPS YoY | 101.7% | · | · | · | · |
Avaliação (TTM) 8
| Métrica | Tendência | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-28M | $-12M | $-6M | $-27M | · | |
| Market Cap | · | · | $4.11B | $3.32B | · | |
| P/E | 105.8 | 460.0 | · | · | · | |
| P/B | · | · | 1148.3 | 223.0 | · | |
| P / Tangible Book | · | · | 380.3 | · | · | |
| P / Cash Flow | · | · | -323.1 | -202.0 | · | |
| P / FCF | · | · | -322.3 | -200.8 | · | |
| Earnings Yield | 0.95% | 0.22% | · | · | · |
Demonstração de Resultados 10
| Métrica | Tendência | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $7M | $6M | $5M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $847.0K | $2M | $1M | |
| SG&A Expense | $2M | $3M | $3M | $3M | $3M | $3M | $1M | $1M | $542.0K | $688.0K | $194.0K | $254.0K | $152.0K | $1M | |
| Operating Expenses | $9M | $9M | $8M | $6M | $5M | $5M | $3M | $3M | $2M | $2M | $1M | $1M | $2M | $6M | |
| Pretax Income | $-9M | $-8M | $-8M | $-7M | $-5M | $-5M | $-3M | $-3M | · | · | · | · | · | · | |
| Income Tax | $21.0K | $10.0K | $0 | $-544.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-9M | $-8M | $-8M | $-6M | $-5M | $-5M | $-3M | $-3M | $-2M | $-2M | $-1M | $-1M | $-2M | $-6M | |
| EPS (Basic) | $0.04 | $0.04 | $0.04 | $0.03 | $0.02 | $0.02 | $0.01 | $0.01 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.04 | $0.04 | $0.04 | $0.03 | $0.02 | $0.02 | $0.01 | $0.01 | · | · | · | · | · | · | |
| Shares (Basic) | 220,996,240 | -457,447,706 | 228,773,418 | 228,173,276 | 228,090,300 | 12,176,266 | 227,956,060 | 216,266,993 | · | · | · | · | · | · | |
| Shares (Diluted) | 220,996,240 | -457,447,706 | 228,773,418 | 228,173,276 | 228,090,300 | 12,176,266 | 227,956,060 | 216,266,993 | · | · | · | · | · | · |
Balanço Patrimonial 19
| Métrica | Tendência | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $14M | $11M | $10M | $14M | $15M | $38M | $45M | $58M | $12M | $7M | $9M | $14M | $18M | |
| Prepaid Expense | $995.0K | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $320.0K | $141.0K | $620.0K | $848.0K | $542.0K | $636.0K | |
| Current Assets | $34M | $42M | $49M | $55M | $59M | $63M | $66M | $69M | $60M | $12M | $7M | $10M | $15M | $18M | |
| PP&E (Net) | $352.0K | $367.0K | $380.0K | $355.0K | $358.0K | $357.0K | $234.0K | $243.0K | $148.0K | $152.0K | $15.0K | $18.0K | $121.0K | $158.0K | |
| PP&E (Gross) | · | $532.0K | · | · | · | $464.0K | · | · | · | $225.0K | · | · | · | · | |
| Accum. Depreciation | · | $165.0K | · | · | · | $107.0K | · | · | · | $73.0K | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $52.0K | $51.0K | $46.0K | $57.0K | |
| Total Assets | $35M | $43M | $50M | $56M | $61M | $64M | $67M | $71M | $60M | $12M | $8M | $10M | $15M | $20M | |
| Accrued Liabilities | $3M | $3M | $3M | $2M | $1M | $555.0K | $637.0K | $977.0K | $2M | $715.0K | $1M | $352.0K | $935.0K | $372.0K | |
| Current Liabilities | $7M | $7M | $5M | $4M | $4M | $3M | $2M | $2M | $5M | $1M | $2M | $2M | $3M | $4M | |
| Capital Leases | $62.0K | $91.0K | $118.0K | $148.0K | $203.0K | $237.0K | $298.0K | $320.0K | $328.0K | $358.0K | $63.0K | $108.0K | $152.0K | $725.0K | |
| Total Liabilities | $7M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | $5M | $2M | $2M | $2M | $4M | $5M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | · | $0 | · | · | · | |
| Paid-in Capital | $102M | $101M | $100M | $99M | $99M | $98M | $97M | $96M | $81M | $34M | $119M | $120M | $120M | $119M | |
| Retained Earnings | $-73M | $-64M | $-56M | $-47M | $-41M | $-36M | $-31M | $-28M | $-25M | $-24M | $-115M | $-112M | $-109M | $-105M | |
| Treasury Stock | $1M | $1M | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $28M | $36M | $45M | $52M | $57M | $61M | $66M | $68M | $55M | $11M | $5M | $8M | $12M | $15M | |
| Liabilities + Equity | $35M | $43M | $50M | $56M | $61M | $64M | $67M | $71M | $60M | $12M | $8M | $10M | $15M | $20M | |
| Shares Outstanding | 232,636,700 | · | 229,015,402 | 228,633,120 | 228,090,300 | · | 227,956,060 | 227,956,060 | 213,959,940 | · | 37,099,352 | 37,099,352 | 37,099,352 | 37,099,352 |
Fluxo de Caixa 11
| Métrica | Tendência | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $484.0K | $740.0K | $836.0K | $761.0K | $874.0K | $1M | $441.0K | $527.0K | $43.0K | $33.0K | $-167.0K | $-112.0K | $46.0K | $89.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $79.0K | $0 | $670.0K | · | |
| Operating Cash Flow | $-7M | $-6M | $-5M | $-6M | $-4M | $-3M | $-3M | $-6M | $-1M | $-2M | $5M | $750.0K | $-2M | $-6M | |
| CapEx | $1.0K | $1.0K | $42.0K | $11.0K | $14.0K | $134.0K | $0 | $102.0K | $3.0K | $1.0K | $3.0K | $-17.0K | $10.0K | $-251.0K | |
| Investing Cash Flow | $14M | $9M | $6M | $2M | $2M | $-20M | $-5M | $-21M | $-2.0K | $-3.0K | $-144.0K | $-5.0K | $-10.0K | $251.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | $45M | · | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $45M | · | · | · | $0 | · | |
| Financing Cash Flow | $0 | $-869.0K | $39.0K | $22.0K | $0 | $-81.0K | $-72.0K | $13M | $48M | $563.0K | $4M | $4M | $500.0K | $0 | |
| Net Change in Cash | $7M | $3M | $858.0K | $-4M | $-1M | $-23M | $-8M | $-13M | $47M | $-995.0K | $9M | $4M | $-1M | $-6M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-444.0K | |
| Free Cash Flow | $-7M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-4M | · |
Lucratividade 2
| Métrica | Tendência | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.2% | · | -13.7% | -9.8% | -8.4% | · | -7.9% | -6.9% | -4.5% | · | -63.7% | -69.5% | -46.6% | · | |
| ROE | -20.5% | · | -14.7% | -10.3% | -9.1% | · | -8.4% | -7.3% | -5.1% | · | -91.5% | -85.4% | -61.2% | · |
Liquidez e Solvência 2
| Métrica | Tendência | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | · | 8.9 | 12.5 | 16.9 | · | 40.4 | 31.9 | 12.9 | · | 3.2 | 5.5 | 4.2 | · | |
| Quick Ratio | 3.0 | · | 2.0 | 2.2 | 3.9 | · | 23.2 | 21.0 | 12.6 | · | 3.0 | 5.0 | 4.0 | · |
Avaliação (TTM) 8
| Métrica | Tendência | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-28M | · | $-22M | $-17M | $-13M | · | $-9M | $-7M | $-6M | · | $-11M | $-14M | $-23M | · | |
| Market Cap | $1.48B | · | $2.28B | $3.38B | $4.38B | · | $10.10B | $17.34B | $24.57B | · | $2.71B | $3.25B | $1.87B | · | |
| P/E | 51.3 | · | 102.7 | 197.3 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 52.9 | · | 51.1 | 65.3 | 76.5 | · | 154.2 | 254.9 | 445.4 | · | 505.8 | 398.8 | 161.4 | · | |
| P / Tangible Book | 52.9 | · | 51.1 | 65.3 | 76.5 | · | 154.2 | 254.9 | 445.4 | · | 505.8 | 398.8 | · | · | |
| P / Cash Flow | -205.9 | · | · | · | -1180.1 | · | · | · | -19003.2 | · | · | · | -527.8 | · | |
| P / FCF | -205.9 | · | · | · | -1175.7 | · | · | · | -18959.2 | · | · | · | -522.8 | · | |
| Earnings Yield | 1.9% | · | 0.97% | 0.51% | · | · | · | · | · | · | · | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|
| Lucro líquido | $-28M | $-12M | $-6M | $-27M | $-14M |
| EPS Diluído | $0.12 | $0.06 | — | — | — |
Balanço Patrimonial
| 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 6.2 | 23.7 | 2.4 | 4.4 | — |
| Índice de Liquidez Seca | 2.0 | 5.7 | 2.1 | 4.4 | — |
Fluxo de Caixa
| 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-20M | $-13M | $-13M | $-17M | — |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.